Former Researcher Sentenced to Seven Years in Prison for Leaking Samsung Electronics’ Semiconductor Technology to China

COMPANY / Reporter Paul Lee / 2026-04-23 06:34:24

Samsung Electronics (Photo = Samsung Electronics)

 

[Alpha Biz= Paul Lee] A former researcher accused of leaking key semiconductor technology from Samsung Electronics to China has been sentenced to seven years in prison.

The Criminal Division 28 of the Seoul Central District Court, presided over by Judge Han Dae-kyun, on April 22 handed down a seven-year prison sentence to a 56-year-old defendant, identified by his surname Jeon, who had been detained and indicted on charges including violations of the Industrial Technology Protection Act.

Jeon was indicted in May last year on charges of leaking Samsung Electronics’ DRAM semiconductor process technology while moving to Chinese chipmaker CXMT, in collusion with a former Samsung Electronics executive identified as Kim.

The leaked technology is reported to be Samsung’s cutting-edge 10-nanometer-class DRAM process, developed as the world’s first of its kind with an investment of approximately KRW 1.6 trillion.

Investigators found that Jeon received a total of KRW 2.9 billion over six years from CXMT in exchange for transferring the technology, including a KRW 300 million signing incentive and stock options worth KRW 300 million.

The court found Jeon guilty on all counts, noting that the case involved the leakage of core national technology and deliberate collusion. “The crime inflicted significant damage not only on the company but also on the Republic of Korea, making severe punishment inevitable,” the court stated.

 

 

 

Alphabiz Reporter Paul Lee(hoondork1977@alphabiz.co.kr)

주요기사

Value Partners Asset Management Criticizes Share Swap Between Shinsegae Food and E-Mart, Citing Governance Concerns
South Korean Government Says Coupang Data Leak Case Will Not Affect U.S. Security Talks
Toss Payment Terminal Expansion Spurs Pushback from VAN Firms Backing Naver Pay
Hanwha Chairman’s Son Kim Dong-sun Leaves Hanwha Corp. to Focus on New Tech-Life Holding Structure
Samsung Biologics Posts Strong Q1 Growth, but Labor Dispute Emerges as Key Risk
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

SNS